Bayer | BAYN - Interest Expense On Debt


Bayer reported EUR675M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Air Liquide EUR 125.9M 3.6M Dec/2025
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 53M 1000K Jun/2026
Amarin USD 3K 5K Dec/2024
Arkema EUR 11M 582M Jun/2025
AstraZeneca USD 340M 144M Jun/2026
BASF EUR 229M 7M Sep/2026
Bayer EUR 675M 87M Dec/2025
Beiersdorf EUR 14M 6.5M Jun/2026
Corteva USD 47M 11M Jun/2026
Covestro EUR 33M 1000K Sep/2025
Essilor EUR 188M 20M Jun/2026
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 83M 4M Jun/2026
Genmab DKK 139M 129M Jun/2026
Givaudan CHF 58M 7M Dec/2025
GlaxoSmithKline GBP 219M 98M Sep/2026
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Johnson Matthey GBP 75M 4M Jun/2024
Linde USD 64M 3M Sep/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 137M 33M Jun/2026
Novartis USD 462M 119M Jun/2026
Nutrien USD 173M 3M Jun/2026
Philips EUR 83M 26M Mar/2026
PPG Industries USD 67M 4M Sep/2026
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR 287M 109M Jun/2026
SAP EUR 287M 36M Sep/2026
Solvay EUR 24M 1000K Jun/2026
UCB EUR 49M 29M Dec/2025
Umicore EUR 36.5M 33.15M Dec/2024
Vinci EUR 798M 35M Jun/2026